Medscape News

Link Description
CHMP Recommends Imraldi, a Biosimilar to Humira The CHMP has recommended Imraldi, a biosimilar to Humira. <br /> <i>International Approvals</i
EU Regulators Limit Symbioflor 2 to Irritable Bowel Syndrome The European Medicines Agency also directed the company that markets the probiotic to conduct a study on how well it treats variants of IBS. <br /> <i>News Alerts</i
CHMP Backs Two Pan-Genotypic Antivirals for Hep C Maviret and Vosevi were evaluated under the European Union's accelerated assessment, which speeds access to new medicines where there is an unmet medical need. <br /> <i>
NSAIDs and CV Risk: The Bottom Line A man with a previous heart attack requires pain management for osteoarthritis. Which agent is safest? <br /> <i>Medscape Internal Medicine</i
Updates From ENDO 2017: Part 1 Join Drs Vega and Anawalt as they discuss hot topics from ENDO 2017, including a new drug class for hot flashes and management of subclinical hypothyroidism in older adults. <br
NOACs for AFib: The Right Dose Matters Dr Arefa Cassoobhoy highlights one of the week's important news stories for primary care. <br /> <i>Medscape Internal Medicine</i
Senate Unveils Bill to Repeal and Replace ACA The Senate Republican bill, crafted behind closed doors, is a softer version of what the House passed in many ways and a harder version in others. <br /> <i>Medscape Medical News
FDA Clears Long-Acting ADHD Drug Mydayis Mydayis (mixed salts of amphetamine) is formulated to last up to 16 hours and is approved for adults and children aged 13 years and older. <br /> <i>FDA Approvals</i
Guns and Kids: What Do We Know About Injuries and Prevention? Drs Kavita Parikh and Michelle Sandberg discuss their recent papers on the topic of gun violence, with advice for clinicians on prevention. <br /> <i>Medscape Pediatrics</i
CMS Eases Eligibility Threshold Again on MIPS Participation The much-anticipated proposed rule would also reduce burdens on physicians who must participate in Medicare's new pay-for-performance program. <br /> <i>Medscape Medical News</i
Poster Pearls From ADA 2017: 13 Things You&#39;ll Be Glad You Know What were some of the unique findings gleaned from the hundreds of posters presented at this year's American Diabetes Association meeting? <br /> <i>Medscape Diabetes
What Do Doctors Really Think About the ACA? Physicians from all over the country tell Medscape about their experiences with the ACA. What's your take? <br /> <i>Medscape Business of Medicine</i
FDA Approves Delafloxacin (Baxdela) for Skin Infections The new antibiotic works against both gram-positive and gram-negative bacteria, including MRSA. <br /> <i>FDA Approvals</i
The Opioid Crisis: Treating the Real Cause The enduring solution to the opioid epidemic lies in addressing the underlying causes and helping people find healing and hope in a world fraught with challenges and pain. <br
Covering All the Bases When Prescribing Insulin Drs Shubrook and Pfotenhauer review the details of prescribing insulin and the importance of ordering all supplies needed for your patients. <br /> <i>Medscape Family Medicine</i